https://www.palestinehealthreport.com/article/910907210-gala-health-under-investigation-high-quality-compounded-glp-1-weight-loss-hormone-therapy-hrt-support Palestine Health Report en PressRelease 2026-05-06T21:09:25+00:00 Gala Health Under Investigation: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support https://zingfast.com/wp-content/uploads/2026/05/Gala-Health.jpg https://www.palestinehealthreport.com/article/910907199-alpha-honey-gummies-claims-evaluated-the-alphahoney-male-enhancement-ingredients-for-virility-enhancing-performance-support Palestine Health Report en PressRelease 2026-05-06T21:09:02+00:00 Alpha Honey Gummies Claims Evaluated: The AlphaHoney Male Enhancement Ingredients for Virility-Enhancing Performance Support https://zingfast.com/wp-content/uploads/2026/05/Alpha-Honey-Gummies.jpg https://www.palestinehealthreport.com/article/910907183-supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference Palestine Health Report en PressRelease 2026-05-06T21:00:52+00:00 Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://www.palestinehealthreport.com/article/910906890-precipio-announces-q1-2026-shareholder-update-call Palestine Health Report en PressRelease 2026-05-06T21:00:00+00:00 Precipio Announces Q1-2026 Shareholder Update Call https://ml.globenewswire.com/media/d80ae417-b29a-4736-afa2-0f5e3beae51b/small/prpo-logo-png.png https://www.palestinehealthreport.com/article/910906946-sanuwave-will-host-a-conference-call-on-may-13-2026-at-8-30-am-et-to-present-q1-2026-financial-results Palestine Health Report en PressRelease 2026-05-06T21:00:00+00:00 Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://www.palestinehealthreport.com/article/910907154-vireo-growth-inc-to-release-first-quarter-results-on-may-12-2026 Palestine Health Report en PressRelease 2026-05-06T20:57:08+00:00 Vireo Growth Inc. to Release First Quarter Results on May 12, 2026 https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.palestinehealthreport.com/article/910894698-argenx-to-present-at-bofa-securities-2026-health-care-conference Palestine Health Report en PressRelease 2026-05-06T20:30:00+00:00 argenx to Present at BofA Securities 2026 Health Care Conference https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.palestinehealthreport.com/article/910894836-alvotech-q1-2026-financial-results Palestine Health Report en PressRelease 2026-05-06T20:30:00+00:00 Alvotech Q1 2026 Financial Results https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://www.palestinehealthreport.com/article/910894898-entrada-therapeutics-to-announce-topline-results-from-cohort-1-of-participants-with-duchenne-muscular-dystrophy-treated-with-entr-601-44-in-phase-1-2 Palestine Health Report en PressRelease 2026-05-06T20:30:00+00:00 Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026 https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png https://www.palestinehealthreport.com/article/910895166-ultragenyx-to-participate-at-bank-of-america-s-2026-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T20:30:00+00:00 Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.palestinehealthreport.com/article/910895508-bionano-announces-leadership-transition Palestine Health Report en PressRelease 2026-05-06T20:30:00+00:00 Bionano Announces Leadership Transition https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.palestinehealthreport.com/article/910895826-context-therapeutics-reports-first-quarter-2026-operating-and-financial-results Palestine Health Report en PressRelease 2026-05-06T20:18:04+00:00 Context Therapeutics Reports First Quarter 2026 Operating and Financial Results https://ml.globenewswire.com/media/67b45666-397e-4c48-af45-ffd653bbfddf/small/context-therapeutics-inc.jpg https://www.palestinehealthreport.com/article/910894880-precision-optics-schedules-third-quarter-of-fiscal-year-2026-conference-call-for-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T20:15:00+00:00 Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026 https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://www.palestinehealthreport.com/article/910895493-dlh-reports-fiscal-2026-second-quarter-results Palestine Health Report en PressRelease 2026-05-06T20:15:00+00:00 DLH Reports Fiscal 2026 Second Quarter Results https://ml.globenewswire.com/media/4efe5f34-0462-4275-ac88-2c8a07c2a9b0/small/dlh-logo-jpg.jpg https://www.palestinehealthreport.com/article/910895725-rapid-micro-biosystems-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T20:15:00+00:00 Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://www.palestinehealthreport.com/article/910895755-biomx-s-zorronet-puts-full-ai-command-and-control-in-the-palm-of-your-hand Palestine Health Report en PressRelease 2026-05-06T20:15:00+00:00 BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand https://ml.globenewswire.com/media/MmRlYTBjOWQtOTQ1ZS00ZmI2LWFlNmUtOThmNmFkMzZhNjNjLTEzMjE4NzEtMjAyNi0wNS0wNi1lbg==/tiny/BiomX.png https://www.palestinehealthreport.com/article/910894744-inspiremd-to-participate-in-upcoming-bank-of-america-securities-2026-global-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.palestinehealthreport.com/article/910894871-imdx-to-release-first-quarter-2026-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 iMDx to Release First Quarter 2026 Results on May 13, 2026 https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png https://www.palestinehealthreport.com/article/910894872-electrocore-announces-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 electroCore Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.palestinehealthreport.com/article/910894884-surrozen-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/f8766f36-378a-41ad-9256-3cf0ca847440/small/logoonly-png.png https://www.palestinehealthreport.com/article/910895148-vaxcyte-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg https://www.palestinehealthreport.com/article/910895158-sight-sciences-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.palestinehealthreport.com/article/910895170-mineralys-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.palestinehealthreport.com/article/910895217-lifemd-reports-first-quarter-2026-results Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 LifeMD Reports First Quarter 2026 Results https://ml.globenewswire.com/media/07c92c99-5645-4be8-a3b7-6d9392b7ccc4/small/lifemd-png.png https://www.palestinehealthreport.com/article/910895221-rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.palestinehealthreport.com/article/910895226-clover-health-reports-first-quarter-2026-results Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Clover Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910895228-zevra-reports-first-quarter-2026-financial-results-and-corporate-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Zevra Reports First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://www.palestinehealthreport.com/article/910895272-tarsus-reports-first-quarter-2026-financial-results-and-recent-business-achievements Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.palestinehealthreport.com/article/910895315-orasure-announces-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 OraSure Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/713ef28e-6d0b-4156-a92f-397061b474cf/small/oti-wordmark-png.png https://www.palestinehealthreport.com/article/910895317-lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-first-quarter-2026 Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026 https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg https://www.palestinehealthreport.com/article/910895418-adma-biologics-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://www.palestinehealthreport.com/article/910895497-tenaya-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/95a7de9f-2b24-4ff3-9b57-f8a35e8c049f/small/tenaya-logo-fullcolor-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910895540-billiontoone-reports-first-quarter-2026-results-and-raises-2026-revenue-guidance Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance https://ml.globenewswire.com/media/888ae54a-648f-4986-998b-84df416858c7/small/billion-to-one-logo-new-jpg.jpg https://www.palestinehealthreport.com/article/910895557-pennant-reports-first-quarter-2026-results Palestine Health Report en PressRelease 2026-05-06T20:05:00+00:00 Pennant Reports First Quarter 2026 Results https://ml.globenewswire.com/media/d50f543c-fc54-437d-8007-600644587dfe/small/pennant-logo-png.png https://www.palestinehealthreport.com/article/910895665-revolution-medicines-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress Palestine Health Report en PressRelease 2026-05-06T20:02:00+00:00 Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.palestinehealthreport.com/article/910894780-argenx-announces-results-of-annual-general-meeting-and-board-of-directors-appointment-of-karen-massey-as-chief-executive-officer Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.palestinehealthreport.com/article/910894802-galapagos-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://www.palestinehealthreport.com/article/910894818-galapagos-rapporteert-financi-le-resultaten-over-het-eerste-kwartaal-van-2026-en-geeft-bedrijfsupdate Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 Galapagos rapporteert financiële resultaten over het eerste kwartaal van 2026 en geeft bedrijfsupdate   https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://www.palestinehealthreport.com/article/910894845-syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.palestinehealthreport.com/article/910894868-bridgebio-to-participate-in-may-and-june-investor-conferences Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 BridgeBio to Participate in May and June Investor Conferences https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.palestinehealthreport.com/article/910894968-journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://www.palestinehealthreport.com/article/910895335-new-2-year-data-from-pivotal-approach-trial-of-transcon-cnp-navepegritide-show-pronounced-gains-in-growth-outcomes-in-children-with-achondroplasia Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.palestinehealthreport.com/article/910895600-mannkind-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 MannKind Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.palestinehealthreport.com/article/910895623-teknova-reports-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-06T20:01:00+00:00 Teknova Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b4992253-8b06-4ba7-93c8-e1f9938c6556/small/updated-teknova-logo-2023-png.png https://www.palestinehealthreport.com/article/910895040-arcutis-announces-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T20:00:00+00:00 Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://www.palestinehealthreport.com/article/910895531-recovery-first-treatment-center-launches-innovative-music-program-where-creative-expression-including-songwriting-supports-recovery Palestine Health Report en PressRelease 2026-05-06T20:00:00+00:00 Recovery First Treatment Center Launches Innovative Music Program Where Creative Expression, Including Songwriting, Supports Recovery https://ml.globenewswire.com/media/df400593-a7d2-41cb-b191-5bd00f158da8/small/recovery-first-logo-jpg.jpg https://www.palestinehealthreport.com/article/910895561-fda-expands-ai-capabilities-and-completes-data-platform-consolidation Palestine Health Report en PressRelease 2026-05-06T19:42:23+00:00 FDA Expands AI Capabilities and Completes Data Platform Consolidation https://ml.globenewswire.com/media/OWJmNDdkNmQtMzYxZS00MzlhLWJkMTctNjkyOTM2M2I1MjFmLTUwMDE1NDE1NC0yMDI2LTA1LTA2LWVu/tiny/FDA.png https://www.palestinehealthreport.com/article/910881420-fda-launches-one-day-inspectional-assessments-to-strengthen-and-expand-oversight Palestine Health Report en PressRelease 2026-05-06T19:33:03+00:00 FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight https://ml.globenewswire.com/media/NTc4OGM2M2MtMTQxYS00NzA5LWJlOWUtNDM4MTA5YmI1OWFhLTUwMDE1NDE1NC0yMDI2LTA1LTA2LWVu/tiny/FDA.png https://www.palestinehealthreport.com/article/910881272-betterguards-acquires-wearable-sports-tech-startup-nextiles Palestine Health Report en PressRelease 2026-05-06T18:41:27+00:00 Betterguards Acquires Wearable Sports Tech Startup Nextiles https://ml.globenewswire.com/media/f9a07229-20f6-43f3-88fd-94b6dad4f8ae/small/bg-logo-png.png https://www.palestinehealthreport.com/article/910855643-walmart-canada-and-children-s-miracle-network-rally-canadians-to-support-kids-health-kick-off-annual-fundraising-campaign Palestine Health Report en PressRelease 2026-05-06T17:34:43+00:00 Walmart Canada and Children’s Miracle Network Rally Canadians to Support Kids’ Health, Kick Off Annual Fundraising Campaign https://ml.globenewswire.com/media/2098ebf6-0983-46f2-8989-a71b94ccd66a/small/lockup-cmn-walmart-png.png https://www.palestinehealthreport.com/article/910855646-walmart-canada-et-children-s-miracle-network-mobilisent-les-canadiens-pour-soutenir-la-sant-des-enfants-et-donnent-le-coup-d-envoi-de-la-campagne Palestine Health Report en PressRelease 2026-05-06T17:34:43+00:00 Walmart Canada et Children's Miracle Network mobilisent les Canadiens pour soutenir la santé des enfants et donnent le coup d’envoi de la campagne annuelle de collecte de fonds https://ml.globenewswire.com/media/2098ebf6-0983-46f2-8989-a71b94ccd66a/small/ https://www.palestinehealthreport.com/article/910855616-diathrive-health-and-kardiacomplete-announce-strategic-partnership-to-address-cardiometabolic-risk Palestine Health Report en PressRelease 2026-05-06T17:17:36+00:00 Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor.png https://www.palestinehealthreport.com/article/910855216-renewa-micro-infusion-system-claims-evaluated-the-painless-skin-microneedling-device-for-at-home-face-lift-treatment Palestine Health Report en PressRelease 2026-05-06T16:47:46+00:00 Renewa Micro-Infusion System Claims Evaluated: The Painless Skin Microneedling Device for At-Home Face Lift Treatment https://zingfast.com/wp-content/uploads/2026/05/Renewa-Micro-Infusion-System.jpg https://www.palestinehealthreport.com/article/910844481-ehealth-exchange-earns-2026-klas-points-of-light-award-for-advancing-digital-quality-measurement-with-bulk-fhir Palestine Health Report en PressRelease 2026-05-06T16:26:00+00:00 eHealth Exchange Earns 2026 KLAS Points of Light Award for Advancing Digital Quality Measurement with Bulk FHIR https://ml.globenewswire.com/media/8cc7b0d1-2d24-41da-b3bc-54e9953144ee/small/ehealth-logo-png.png https://www.palestinehealthreport.com/article/910844278-paremina-selected-as-preferred-brand-for-swiss-longevity-supplements-in-luxury-hospitality Palestine Health Report en PressRelease 2026-05-06T16:19:00+00:00 Paremina selected as Preferred Brand for Swiss Longevity Supplements in Luxury Hospitality https://pressranger.s3.us-west-1.amazonaws.com/3255602/paremina-banner.jpg https://www.palestinehealthreport.com/article/910844105-sage-dental-expands-national-reach-through-strategic-partnership-with-curaechoice Palestine Health Report en PressRelease 2026-05-06T16:07:00+00:00 Sage Dental Expands National Reach Through Strategic Partnership with Curaechoice https://ml.globenewswire.com/media/a74a7291-6b73-4b11-8a1a-4544f792b484/small/screenshot-2025-11-04-at-10-27-29-am-png.png https://www.palestinehealthreport.com/article/910844035-carbogen-amcis-shanghai-site-achieves-successful-outcome-in-unannounced-nmpa-gmp-inspection Palestine Health Report en PressRelease 2026-05-06T16:04:06+00:00 CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection https://ml-eu.globenewswire.com/media/fb9efd55-1cdf-42ee-96bb-60d199a0683d/medium/carbogen-amcis-shanghai.jpg https://www.palestinehealthreport.com/article/910831823-robotic-companion-pets-from-ageless-innovation-reach-750-000-adoptions-supporting-well-being-for-older-adults Palestine Health Report en PressRelease 2026-05-06T15:27:48+00:00 Robotic Companion Pets from Ageless Innovation Reach 750,000 Adoptions Supporting Well-Being for Older Adults https://ml.globenewswire.com/media/27dc8195-26bc-4a35-9909-ab9e10b37803/small/ageless-innovation-logo-png.png https://www.palestinehealthreport.com/article/910831628-trethera-to-present-optic-neuritis-research-at-los-angeles-bioscience-ecosystem-summit-2026 Palestine Health Report en PressRelease 2026-05-06T15:25:00+00:00 Trethera To Present Optic Neuritis Research at Los Angeles Bioscience Ecosystem Summit 2026 https://ml.globenewswire.com/media/58f1dd8e-4737-42db-950e-17f8d4a0a486/medium/fig-1.png https://www.palestinehealthreport.com/article/910831720-nearly-half-of-americans-are-aware-of-the-new-dietary-guidelines-for-americans-new-food-pyramid-within-weeks-of-their-debut Palestine Health Report en PressRelease 2026-05-06T14:55:43+00:00 Nearly Half Of Americans Are Aware Of The New Dietary Guidelines for Americans & New Food Pyramid Within Weeks Of Their Debut https://ml.globenewswire.com/media/MWIwMGYyZGYtZjY0OS00YTdjLWFjMDktOWI0Y2JkMGZmNmQzLTEwOTg2ODEtMjAyNi0wNS0wNi1lbg==/tiny/International-Food-Information.png https://www.palestinehealthreport.com/article/910820002-becoming-independent-celebrates-outstanding-individuals-and-partners-at-second-annual-spotlight-awards Palestine Health Report en PressRelease 2026-05-06T14:00:00+00:00 Becoming Independent Celebrates Outstanding Individuals and Partners at Second Annual Spotlight Awards https://ml.globenewswire.com/media/bd5bec97-a0fe-41ab-8908-7c2fdc06d56d/medium/advocate-of-the-year-erik-son-nancy-mietz-mother.jpg https://www.palestinehealthreport.com/article/910820065-twentyeight-health-partners-with-ura-to-expand-access-to-comprehensive-contraceptive-care Palestine Health Report en PressRelease 2026-05-06T13:50:00+00:00 Twentyeight Health Partners with ŌURA to Expand Access to Comprehensive Contraceptive Care https://ml.globenewswire.com/media/ab364761-0cc6-4c5e-9483-815a4f74e08a/small/twentyeight-health-logo-jpg.jpg https://www.palestinehealthreport.com/article/910808741-better-blend-continues-growth-with-second-lexington-location Palestine Health Report en PressRelease 2026-05-06T13:40:01+00:00 Better Blend Continues Growth with Second Lexington Location https://ml.globenewswire.com/media/b9ef98e3-35e0-407c-a76c-27dedd72308f/medium/better-blend-mobile-pick-up-lane.jpg https://www.palestinehealthreport.com/article/910808739-american-kidney-fund-and-akf-ambassadors-on-capitol-hill-for-annual-akf-kidney-action-summit Palestine Health Report en PressRelease 2026-05-06T13:25:11+00:00 American Kidney Fund and AKF Ambassadors on Capitol Hill for Annual AKF Kidney Action Summit https://ml.globenewswire.com/media/MjEwYTRjNTgtYjJhZS00ZjFkLThmM2QtOTY3ZjMyMTQ3MDYzLTExMDkwNTItMjAyNi0wNS0wNi1lbg==/tiny/American-Kidney-Fund.png https://www.palestinehealthreport.com/article/910808605-american-nurses-enterprise-kicks-off-national-nurses-week-celebrations Palestine Health Report en PressRelease 2026-05-06T13:11:26+00:00 American Nurses Enterprise Kicks Off National Nurses Week Celebrations https://ml.globenewswire.com/media/NzE3N2RjNmMtODY3Ny00NjRkLWE4NTAtOTkwYzUxNzFlMzY2LTUwMDE2MTk2Mi0yMDI2LTA1LTA2LWVu/tiny/American-Nurses-Enterprise.png https://www.palestinehealthreport.com/article/910808594-joint-commission-and-nachc-announce-strategic-partnership-to-support-community-health-centers-and-patients Palestine Health Report en PressRelease 2026-05-06T13:06:53+00:00 Joint Commission and NACHC Announce Strategic Partnership to Support Community Health Centers and Patients https://ml.globenewswire.com/media/ZGE0OGM2NWEtNmYyNi00OWJjLWFjYmMtMTExNDUxYzlkNDIzLTUwMDE1ODA0Ny0yMDI2LTA1LTA2LWVu/tiny/Joint-Commission.png https://www.palestinehealthreport.com/article/910808189-tekton-research-appoints-dr-amit-vijapura-as-central-nervous-system-key-opinion-leader Palestine Health Report en PressRelease 2026-05-06T13:05:00+00:00 Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion Leader https://ml.globenewswire.com/media/3de70544-645a-462a-b864-880c614f0792/small/logo-tekton-png.png https://www.palestinehealthreport.com/article/910808546-hope-air-marks-40-years-of-changing-health-outcomes-for-patients-needing-to-travel-long-distances-for-care Palestine Health Report en PressRelease 2026-05-06T13:05:00+00:00 Hope Air Marks 40 Years of Changing Health Outcomes for Patients Needing to Travel Long Distances for Care https://ml.globenewswire.com/media/d3681ff3-0b3f-4075-9888-0309ed73c339/small/hope-air-logo-png.png https://www.palestinehealthreport.com/article/910808179-jito-foundation-and-solana-company-nasdaq-hsdt-announce-strategic-partnership-to-expand-institutional-solana-infrastructure-across-asia-pacific Palestine Health Report en PressRelease 2026-05-06T13:00:00+00:00 Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region https://ml.globenewswire.com/media/1986b97e-8656-4213-9218-ae51324d696d/small/solana-company-main-black-png.png https://www.palestinehealthreport.com/article/910808363-medwell-ai-inc-reports-q3-revenues-of-618-676-and-provides-corporate-update Palestine Health Report en PressRelease 2026-05-06T13:00:00+00:00 MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update https://ml.globenewswire.com/media/20f2b978-0b1a-4796-8177-6c597fd8e4c2/small/mwai-png.png https://www.palestinehealthreport.com/article/910808475-nexgel-appoints-brian-kieser-and-kevin-harris-from-new-strategic-partner-sequence-lifescience-to-board-of-directors Palestine Health Report en PressRelease 2026-05-06T13:00:00+00:00 NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.palestinehealthreport.com/article/910808510-bioadaptives-inc-launches-myndrenew-to-complete-the-24-hour-brain-performance-cycle Palestine Health Report en PressRelease 2026-05-06T12:54:00+00:00 BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle https://ml.globenewswire.com/media/ad289631-6a2e-4b27-bc43-6b7ac688a537/small/bioadaptives-logo-jpg.jpg https://www.palestinehealthreport.com/article/910808159-actuate-therapeutics-announces-key-appointment-of-industry-veteran-to-board-of-directors Palestine Health Report en PressRelease 2026-05-06T12:45:00+00:00 Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://www.palestinehealthreport.com/article/910796897-latest-pharmaceutical-suppositories-market-size-to-hit-usd-13-4-bn-at-a-cagr-of-3-5-by-2034-report-by-zion-market-research Palestine Health Report en PressRelease 2026-05-06T12:41:14+00:00 [Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.palestinehealthreport.com/article/910796652-where-executives-are-doubling-down-on-their-companies-fortunes Palestine Health Report en PressRelease 2026-05-06T12:35:00+00:00 Where Executives Are Doubling Down on Their Companies’ Fortunes https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://www.palestinehealthreport.com/article/910796841-ernexa-therapeutics-unveils-breakthrough-preclinical-results-erna-101-achieves-100-survival-and-complete-tumor-elimination-in-ovarian-cancer-models Palestine Health Report en PressRelease 2026-05-06T12:33:00+00:00 Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.palestinehealthreport.com/article/910795980-bioxodes-presents-positive-final-phase-2a-intracerebral-hemorrhage-results-at-esoc-affirming-breakthrough-potential-of-biox-101 Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101 https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://www.palestinehealthreport.com/article/910796094-pliant-therapeutics-to-participate-in-the-rbc-capital-markets-global-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.palestinehealthreport.com/article/910796098-veru-to-report-fiscal-2026-second-quarter-financial-results-on-may-13th Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th https://ml.globenewswire.com/media/9c96f1a7-e104-47d4-8011-8c19496681c2/small/final-veruinclogo-rgb-300dpi-jpg.jpg https://www.palestinehealthreport.com/article/910796167-allogene-therapeutics-to-report-first-quarter-financial-results-and-provide-business-update Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.palestinehealthreport.com/article/910796329-cristcot-appoints-rayna-herman-as-president-of-its-hydrocortisone-acetate-commercial-division Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division https://ml.globenewswire.com/media/ODc0YjM4OTItZWNkZi00ZWU2LThmY2QtYTFhZGNiMmFjMTE4LTEzMjI0MTAtMjAyNi0wNS0wNi1lbg==/tiny/Cristcot-LLC.png https://www.palestinehealthreport.com/article/910796657-oncotelic-therapeutics-announces-closing-of-a-strategic-monetization-of-its-cns-nasal-assets-with-lunai-bioworks-advancing-joint-development-in Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.palestinehealthreport.com/article/910796713-cdt-advances-azd5904-into-global-patent-phase-and-initiates-partnering-discussions Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions https://ml.globenewswire.com/media/Y2YxYWQ5NTgtMDg3ZC00NGRlLTlkMmItODk2Zjk4YTAxYTg4LTEyNzQxMDItMjAyNi0wNS0wNi1lbg==/tiny/CDT-Equity-Inc-.png https://www.palestinehealthreport.com/article/910796774-crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.palestinehealthreport.com/article/910796861-inflarx-announces-pricing-of-150-million-underwritten-offering-of-ordinary-shares Palestine Health Report en PressRelease 2026-05-06T12:30:00+00:00 InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.palestinehealthreport.com/article/910796856-inflarx-announces-advancement-of-izicopan-in-anca-associated-vasculitis-and-select-renal-diseases Palestine Health Report en PressRelease 2026-05-06T12:25:00+00:00 InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.palestinehealthreport.com/article/910796721-scienture-announces-third-patent-grant-for-arbli-losartan-potassium-oral-suspension-strengthening-long-term-market-exclusivity-through-2041 Palestine Health Report en PressRelease 2026-05-06T12:05:00+00:00 SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 https://ml.globenewswire.com/media/492f1bb3-8792-47f3-81e5-15dd04df46b4/small/logo-png.png https://www.palestinehealthreport.com/article/910796254-orchestra-biomed-receives-15-million-investment-from-ligand-under-previously-announced-strategic-financing-agreement Palestine Health Report en PressRelease 2026-05-06T12:01:00+00:00 Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.palestinehealthreport.com/article/910796015-aktis-oncology-to-present-at-the-bofa-securities-health-care-conference Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Aktis Oncology to Present at the BofA Securities Health Care Conference https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.palestinehealthreport.com/article/910796024-abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors https://ml.globenewswire.com/media/b771ed66-3175-44f5-be35-7c3c380f64a1/small/abli-tx-jpg.jpg https://www.palestinehealthreport.com/article/910796040-annexon-to-present-at-the-bank-of-america-securities-health-care-conference-2026 Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Annexon to Present at the Bank of America Securities Health Care Conference 2026 https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.palestinehealthreport.com/article/910796051-in8bio-to-showcase-next-generation-t-cell-engager-platform-and-new-clinical-data-at-upcoming-r-d-day-and-medical-conferences Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.palestinehealthreport.com/article/910796111-pathos-ai-acquires-majority-stake-in-deuteroncology-to-advance-next-generation-met-inhibitor-identified-by-pathos-foundry-platform Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform https://ml.globenewswire.com/media/3a9007f6-d394-44fa-adf5-606bbb9d5d85/small/pr-image-png.png https://www.palestinehealthreport.com/article/910796113-milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.palestinehealthreport.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.palestinehealthreport.com/article/910796216-rhythm-pharmaceuticals-announces-participation-in-upcoming-bank-of-america-global-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.palestinehealthreport.com/article/910796223-orchestra-biomed-receives-20-million-payment-from-medtronic-under-previously-announced-financing-agreement Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.palestinehealthreport.com/article/910796232-urogen-reports-zusduri-revenue-more-than-doubled-quarter-over-quarter-and-provides-first-quarter-2026-financial-results-and-highlights Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://www.palestinehealthreport.com/article/910796338-pds-biotech-announces-conference-call-and-webcast-for-2026-first-quarter-financial-results Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results https://ml.globenewswire.com/media/e2e7d124-dbd4-4140-9cc5-449d3488a902/small/pds-biotech-logo-png.png https://www.palestinehealthreport.com/article/910796344-crysvita-now-publicly-reimbursed-for-the-treatment-of-adults-with-xlh-in-four-provinces-and-federal-non-insured-health-benefits-program Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program https://ml.globenewswire.com/media/a3a8a24d-ccff-49c4-baf1-bf8e8a7a2551/small/img-ogp-1755267550540-png.png https://www.palestinehealthreport.com/article/910796347-crysvita-mc-est-d-sormais-rembours-par-les-r-gimes-publics-pour-le-traitement-des-adultes-atteints-d-xlh-dans-quatre-provinces-et-dans-le-cadre-du Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 CRYSVITA(MC) est désormais remboursé par les régimes publics pour le traitement des adultes atteints d’XLH dans quatre provinces et dans le cadre du Programme fédéral des services de santé non assurés https://ml.globenewswire.com/media/a3a8a24d-ccff-49c4-baf1-bf8e8a7a2551/small/img-ogp-1755267550540-png.png https://www.palestinehealthreport.com/article/910796373-erasca-to-present-at-the-bank-of-america-securities-health-care-conference Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Erasca to Present at the Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.palestinehealthreport.com/article/910796402-brain-cancer-canada-awards-75-000-to-groundbreaking-pediatric-brain-cancer-study-at-university-of-manitoba-targeting-hard-to-treat-dmg-p-tumours Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.palestinehealthreport.com/article/910796679-polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T12:00:00+00:00 PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 https://ml.globenewswire.com/media/202fc254-aac1-49c2-a08d-cc0efc938460/small/polypid-logo-final-rgb-2x-100-jpg.jpg https://www.palestinehealthreport.com/article/910784580-kura-oncology-to-participate-in-bank-of-america-securities-healthcare-conference Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Kura Oncology to Participate in Bank of America Securities Healthcare Conference https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.palestinehealthreport.com/article/910784610-beyonttra-acoramidis-the-first-near-complete-ttr-stabilizer-90-approved-by-anvisa-to-treat-attr-cm-in-brazil Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.palestinehealthreport.com/article/910784618-medicus-pharma-announces-results-from-pre-specified-expanded-phase-2-sknjct-003-data-analysis-demonstrating-positive-dose-response Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.palestinehealthreport.com/article/910784675-cronos-expands-pre-roll-portfolio-with-spinach-stix Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Cronos Expands Pre-Roll Portfolio with Spinach STIX® https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://www.palestinehealthreport.com/article/910784783-bioventus-reports-first-quarter-financial-results Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Bioventus Reports First Quarter Financial Results https://ml.globenewswire.com/media/e10db184-593a-40b5-af02-627c27583108/small/bioventus-logo-png.png https://www.palestinehealthreport.com/article/910784806-medline-reports-first-quarter-2026-results Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Medline Reports First Quarter 2026 Results https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://www.palestinehealthreport.com/article/910784827-immusoft-to-present-data-highlighting-positive-results-from-the-world-s-first-engineered-b-cell-in-a-human-clinical-trial-at-asgct-2026 Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026 https://ml.globenewswire.com/media/4a461fce-d4b2-46be-b0e5-da2737c3eb90/small/immusoft-logo-jpg.jpg https://www.palestinehealthreport.com/article/910784844-altimmune-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.palestinehealthreport.com/article/910784933-briacell-receives-fda-clearance-to-initiate-bria-bres-clinical-study-in-breast-cancer Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer https://ml.globenewswire.com/media/cf1af19a-fd92-49b4-8e39-fb9b1c4191a7/medium/figure-1.jpg https://www.palestinehealthreport.com/article/910785001-crescent-biopharma-to-present-at-may-investor-conferences Palestine Health Report en PressRelease 2026-05-06T11:30:00+00:00 Crescent Biopharma to Present at May Investor Conferences https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.palestinehealthreport.com/article/910785004-lifecore-biomedical-reports-financial-results-for-the-first-quarter-ended-march-31-2026-and-provides-corporate-update Palestine Health Report en PressRelease 2026-05-06T11:05:00+00:00 Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://www.palestinehealthreport.com/article/910784577-immunocore-reports-first-quarter-financial-results-and-provides-a-business-update Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Immunocore reports first quarter financial results and provides a business update https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://www.palestinehealthreport.com/article/910784599-kymera-therapeutics-to-participate-in-upcoming-may-investor-conferences Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Kymera Therapeutics to Participate in Upcoming May Investor Conferences https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.palestinehealthreport.com/article/910784602-relmada-therapeutics-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026 Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.palestinehealthreport.com/article/910784604-aquestive-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-business-highlights-on-may-13-and-host-conference-call-on-may-14-at Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.palestinehealthreport.com/article/910784613-kamada-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/6334b598-e958-4ac2-b196-aac2c24ea458/small/picture1-jpg.jpg https://www.palestinehealthreport.com/article/910784623-tscan-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/d8d2632e-0ce4-4ed2-940e-22a1c599d43f/small/tscan-logo-png.png https://www.palestinehealthreport.com/article/910784703-eyepoint-reports-first-quarter-2026-financial-results-and-highlights-recent-corporate-developments Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://www.palestinehealthreport.com/article/910784717-biocryst-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910784760-geron-corporation-reports-first-quarter-2026-financial-results-and-recent-business-highlights Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.palestinehealthreport.com/article/910784850-madrigal-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.palestinehealthreport.com/article/910784964-tonix-pharmaceuticals-secures-commercial-payer-coverage-for-tonmya-providing-access-for-35-million-u-s-patients Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.palestinehealthreport.com/article/910784982-tempest-presents-clinical-update-at-isct-2026-annual-meeting Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Tempest Presents Clinical Update at ISCT 2026 Annual Meeting https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.palestinehealthreport.com/article/910784997-anavex-life-sciences-board-of-directors-appoints-former-senior-vice-president-of-clinical-development-terrie-kellmeyer-phd-as-interim-chief Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png https://www.palestinehealthreport.com/article/910785011-eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b-2a-resolve-trial-in-eosinophilic-esophagitis-at-digestive Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.palestinehealthreport.com/article/910785064-hyperion-defi-announces-pricing-of-public-offering-of-common-stock Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 Hyperion DeFi Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.palestinehealthreport.com/article/910785142-tg-therapeutics-reports-first-quarter-2026-financial-results-and-raises-briumvi-revenue-guidance Palestine Health Report en PressRelease 2026-05-06T11:00:00+00:00 TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.palestinehealthreport.com/article/910772607-mannkind-announces-ralinepag-dry-powder-inhalation-dpi-program-to-be-pursued-for-pulmonary-hypertension-and-fibrotic-lung-diseases Palestine Health Report en PressRelease 2026-05-06T10:30:00+00:00 MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.palestinehealthreport.com/article/910772795-recursion-reports-first-quarter-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-06T10:30:00+00:00 Recursion Reports First Quarter Financial Results and Provides Business Update https://ml.globenewswire.com/media/d2751ce2-f602-4ebf-b6b6-8acff83456f5/medium/recursions-wholly-owned-pipeline.jpg https://www.palestinehealthreport.com/article/910772628-people-living-with-cancer-caregivers-urge-congress-to-expand-access-to-whole-person-supportive-cancer-care-as-part-of-national-summit Palestine Health Report en PressRelease 2026-05-06T10:00:00+00:00 People Living with Cancer, Caregivers Urge Congress to Expand Access to Whole-Person Supportive Cancer Care As Part of National Summit https://ml.globenewswire.com/media/NjdlODk0YzAtNDZmNS00YmU0LWFmMjItZDk0MDc1OTc3ZmFhLTUwMDE2MjE3My0yMDI2LTA1LTA2LWVu/tiny/The-Sheri-and-Les-Biller-Famil.png https://www.palestinehealthreport.com/article/910772798-aclarion-announces-inducement-grant-to-new-commercial-director-western-u-s Palestine Health Report en PressRelease 2026-05-06T10:00:00+00:00 Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.palestinehealthreport.com/article/910730182-immutrin-appoints-leading-cardiovascular-drug-development-expert-dr-robert-blaustein-as-chief-medical-officer-and-establishes-us-subsidiary Palestine Health Report en PressRelease 2026-05-06T06:00:00+00:00 Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary https://ml-eu.globenewswire.com/media/b8f96d3c-b61d-4f73-8c17-929d628c2984/small/image-2immutrin-jpg.jpg https://www.palestinehealthreport.com/article/910730186-avacta-presents-new-comparisons-of-pre-cision-payload-release-vs-approved-adcs-and-ava6207-dual-payload-delivery-at-science-day-2026 Palestine Health Report en PressRelease 2026-05-06T06:00:00+00:00 Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.palestinehealthreport.com/article/910719259-philips-delivers-strong-order-intake-comparable-sales-growth-and-margin-expansion-in-q1-2026-outlook-reiterated Palestine Health Report en PressRelease 2026-05-06T05:00:00+00:00 Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.palestinehealthreport.com/article/910696959-avalo-therapeutics-announces-pricing-of-375-million-public-offering Palestine Health Report en PressRelease 2026-05-06T03:33:54+00:00 Avalo Therapeutics Announces Pricing of $375 Million Public Offering https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.palestinehealthreport.com/article/910696876-lbl-047-prioritized-for-clinical-development-in-sj-gren-s-disease-systemic-lupus-erythematosus-and-dermatomyositis Palestine Health Report en PressRelease 2026-05-06T02:57:21+00:00 LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis https://ml.globenewswire.com/media/YjZkMjQxNjctYjA3Ni00YmZkLThkMGMtZDhmZTMzNGI3ZTMxLTEzMDgzODktMjAyNi0wNS0wNi1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.palestinehealthreport.com/article/910686158-writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap-and-birp-note-generation-at-ca-40-per-user Palestine Health Report en PressRelease 2026-05-06T02:45:54+00:00 WriteUpp Introduces Embedded AI Medical Scribe With SOAP, DAP and BIRP Note Generation at CA$40 Per User https://ml.globenewswire.com/media/a75e2abd-2872-4427-9104-2e700e6a8340/medium/writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap.png https://www.palestinehealthreport.com/article/910661966-rapid-nutrition-enhances-investor-access-with-agentic-ai-driven-on-demand-communication-platform Palestine Health Report en PressRelease 2026-05-06T00:27:06+00:00 Rapid Nutrition Enhances Investor Access with Agentic AI driven On-Demand Communication Platform https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.palestinehealthreport.com/article/910636745-isothrive-reports-highly-statistically-significant-phase-2-data-for-mhs-1031-in-nerd-patients-at-ddw-2026 Palestine Health Report en PressRelease 2026-05-05T22:16:13+00:00 ISOThrive Reports Highly Statistically Significant Phase 2 Data for MHS-1031 in NERD Patients at DDW 2026 https://ml.globenewswire.com/media/bbf9967c-a7fb-4fa6-b7e7-3cab0c0479b9/medium/cover-image.jpg https://www.palestinehealthreport.com/article/910624511-biomea-fusion-announces-poster-presentations-of-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions Palestine Health Report en PressRelease 2026-05-05T21:50:41+00:00 Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions https://ml.globenewswire.com/media/d2f051eb-da8d-4233-9093-8ff1579d035f/small/biomea-fusion-logo-rgb-rev2-email-png.png https://www.palestinehealthreport.com/article/910624458-mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Palestine Health Report en PressRelease 2026-05-05T21:34:32+00:00 Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.palestinehealthreport.com/article/910624423-epik-biosciences-launches-to-pioneer-ketamine-powered-psychedelic-therapies-to-transform-treatment-of-mental-health-pain-and-addiction Palestine Health Report en PressRelease 2026-05-05T21:20:00+00:00 EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction https://ml.globenewswire.com/media/3ffb3db0-76c3-46ee-84b6-368a18fbeefc/small/epik-png.png https://www.palestinehealthreport.com/article/910612410-aura-biosciences-announces-closing-of-299-million-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares Palestine Health Report en PressRelease 2026-05-05T21:15:00+00:00 Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.palestinehealthreport.com/article/910611978-steris-announces-dividend-of-0-63-per-share Palestine Health Report en PressRelease 2026-05-05T20:30:00+00:00 STERIS Announces Dividend of $0.63 per share https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.palestinehealthreport.com/article/910612071-theriva-biologics-reports-first-quarter-2026-operational-highlights-and-financial-results Palestine Health Report en PressRelease 2026-05-05T20:30:00+00:00 Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://www.palestinehealthreport.com/article/910612085-fda-expands-market-access-authorizes-new-ends-products Palestine Health Report en PressRelease 2026-05-05T20:27:48+00:00 FDA Expands Market Access, Authorizes New ENDS Products https://ml.globenewswire.com/media/YjBiNDNiOTUtOGFkYi00NDg0LTlhYmMtYzJjNWJlNjIxNmY2LTUwMDE1NDE1NC0yMDI2LTA1LTA1LWVu/tiny/FDA.png https://www.palestinehealthreport.com/article/910612052-pacira-biosciences-mails-letter-to-stockholders Palestine Health Report en PressRelease 2026-05-05T20:20:00+00:00 Pacira BioSciences Mails Letter to Stockholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.palestinehealthreport.com/article/910599747-longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-05T20:15:00+00:00 Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026 https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599971-sienna-reports-first-quarter-2026-financial-results-and-continues-platform-expansion Palestine Health Report en PressRelease 2026-05-05T20:15:00+00:00 Sienna Reports First Quarter 2026 Financial Results and Continues Platform Expansion https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Palestine Health Report en PressRelease 2026-05-05T20:15:00+00:00 Cytokinetics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.palestinehealthreport.com/article/910599138-onkure-therapeutics-reports-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 OnKure Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b01f7b95-9b60-4b2b-8515-fe0cae183fff/small/onkure-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599159-sana-biotechnology-to-present-at-the-bofa-securities-2026-healthcare-conference Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://www.palestinehealthreport.com/article/910599164-spero-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599178-korro-to-participate-in-upcoming-investor-conferences Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Korro to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910599236-alamar-biosciences-to-participate-in-bofa-securities-2026-healthcare-conference Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://www.palestinehealthreport.com/article/910599247-trevi-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599249-adaptive-biotechnologies-reports-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Adaptive Biotechnologies Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.palestinehealthreport.com/article/910599357-myriad-genetics-reports-first-quarter-2026-financial-results-reiterates-2026-financial-guidance-reflecting-ongoing-progress-in-the-cancer-care Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.palestinehealthreport.com/article/910599397-iridex-to-report-first-quarter-2026-financial-results-on-may-19-2026 Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://www.palestinehealthreport.com/article/910599618-amwell-announces-results-for-first-quarter-2026 Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Amwell® Announces Results for First Quarter 2026 https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.palestinehealthreport.com/article/910599661-avalo-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.palestinehealthreport.com/article/910599743-innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026 Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910599766-standard-biotools-reports-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Standard BioTools Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://www.palestinehealthreport.com/article/910599869-relay-therapeutics-reports-first-quarter-2026-financial-results-and-corporate-updates Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.palestinehealthreport.com/article/910600015-supernus-announces-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Supernus Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://www.palestinehealthreport.com/article/910600051-lemaitre-q1-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 LeMaitre Q1 2026 Financial Results https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.palestinehealthreport.com/article/910600067-verrica-pharmaceuticals-announces-upcoming-presentation-of-phase-2-data-highlighting-the-potential-abscopal-effects-of-vp-315-in-the-treatment-of Palestine Health Report en PressRelease 2026-05-05T20:05:00+00:00 Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting  https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599241-carlsmed-reports-first-quarter-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Carlsmed® Reports First Quarter 2026 Financial Results  https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://www.palestinehealthreport.com/article/910599255-dianthus-therapeutics-highlights-recent-business-achievements-and-reports-q1-2026-financial-results Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png https://www.palestinehealthreport.com/article/910599363-monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://www.palestinehealthreport.com/article/910599377-avalyn-to-present-patient-centered-research-on-ap01-delivery-and-supportive-care-experiences-at-american-thoracic-society-2026-international Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.palestinehealthreport.com/article/910599422-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.palestinehealthreport.com/article/910599496-ligand-to-participate-in-may-investor-conferences Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Ligand to Participate in May Investor Conferences https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.palestinehealthreport.com/article/910599599-ultragenyx-reports-first-quarter-2026-financial-results-and-corporate-update Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.palestinehealthreport.com/article/910599621-dentsply-sirona-reports-first-quarter-2026-results Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Dentsply Sirona Reports First Quarter 2026 Results https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://www.palestinehealthreport.com/article/910599629-avalo-therapeutics-achieves-positive-topline-results-in-phase-2-lotus-trial-of-abdakibart-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.palestinehealthreport.com/article/910599881-hyperion-defi-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.palestinehealthreport.com/article/910599936-healthequity-announces-first-quarter-earnings-release-date-and-investor-conference-schedule Palestine Health Report en PressRelease 2026-05-05T20:01:00+00:00 HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule https://ml.globenewswire.com/media/30a1510d-03b1-4356-b38d-e9f75f1ec797/small/healthequitylogo-purple-2020-jpg.jpg https://www.palestinehealthreport.com/article/910599226-acumen-pharmaceuticals-to-report-first-quarter-financial-results-on-may-12-2026 Palestine Health Report en PressRelease 2026-05-05T20:00:00+00:00 Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://www.palestinehealthreport.com/article/910599338-inmune-bio-and-anthony-nolan-announce-strategic-expansion-of-cordstrom-msc-platform-collaboration-to-target-rdeb-oncology-and-inflammatory-diseases Palestine Health Report en PressRelease 2026-05-05T20:00:00+00:00 INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.palestinehealthreport.com/article/910587066-context-by-fulcra-dynamics-launches-updated-version-2-4-7-now-with-the-capacity-for-groups Palestine Health Report en PressRelease 2026-05-05T19:22:00+00:00 Context, by Fulcra Dynamics, Launches Updated Version 2.4.7 - Now With the Capacity for Groups https://pressranger.s3.us-west-1.amazonaws.com/3254028/active_tab.png https://www.palestinehealthreport.com/article/910587060-neuvasq-presents-data-showcasing-promising-novel-multispecific-gpr124-targeting-antibodies-for-blood-retina-barrier-restoration-at-arvo-2026 Palestine Health Report en PressRelease 2026-05-05T19:15:00+00:00 Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026 https://ml.globenewswire.com/media/758fbb1f-ac3c-4f37-ba02-64c0f59beff0/small/neuvasq-logo-png-png.png https://www.palestinehealthreport.com/article/910576181-sk-pharmteco-obtient-la-validation-de-la-sbti-pour-ses-objectifs-scientifiques-de-neutralit-carbone-horizon-2040 Palestine Health Report en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.palestinehealthreport.com/article/910576183-sk-pharmteco-erh-lt-sbti-validierung-f-r-wissenschaftsbasierte-netto-null-ziele-bis-2040 Palestine Health Report en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco erhält SBTi-Validierung für wissenschaftsbasierte Netto-Null-Ziele bis 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.palestinehealthreport.com/article/910576185-sk-pharmteco-2040-sbti Palestine Health Report en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco, 2040년 넷제로 과학 기반 목표에 대한 글로벌 기후변화 대응 이니셔티브 (SBTi) 검증 획득 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.palestinehealthreport.com/article/910576128-the-association-of-american-physicians-and-surgeons-files-in-the-u-s-supreme-court-in-opposition-to-mifepristone-abortion-by-mail Palestine Health Report en PressRelease 2026-05-05T18:15:52+00:00 The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail https://ml.globenewswire.com/media/NThiZDE0ODctMDBhNC00N2UzLTkzZmMtNDUwYzc2ZTU0MjkzLTEwMzM1MTctMjAyNi0wNS0wNS1lbg==/tiny/Association-of-American-Physic.png https://www.palestinehealthreport.com/article/910565807-mesa-laboratories-inc-to-announce-fourth-quarter-and-full-fiscal-year-results-on-may-27-2026 Palestine Health Report en PressRelease 2026-05-05T17:39:00+00:00 Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 https://ml.globenewswire.com/media/ff66b401-9246-47b9-accc-2f553d346c5c/small/mesalogo-jpg.jpg https://www.palestinehealthreport.com/article/910565759-hantavirus-cluster-linked-to-cruise-ship-highlights-ongoing-zoonotic-risk-and-the-need-for-vigilance Palestine Health Report en PressRelease 2026-05-05T17:20:00+00:00 Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.palestinehealthreport.com/article/910565666-ergodyne-mips-bring-another-head-protection-first-to-worksites Palestine Health Report en PressRelease 2026-05-05T17:15:00+00:00 Ergodyne + Mips Bring Another Head Protection First to Worksites https://ml.globenewswire.com/media/NGEwMDhhNTMtYmMwNC00ODBmLWJiMGItMmMzNjU3MWQ4MjdlLTExODg4MTAtMjAyNi0wNS0wNS1lbg==/tiny/Ergodyne.png https://www.palestinehealthreport.com/article/910565583-smith-nephew-drives-progress-in-chronic-wound-care-with-allevyn-complete-care-dressing-and-renasys-edge-tnpwt-set-to-launch-at-ewma-2026 Palestine Health Report en PressRelease 2026-05-05T17:00:00+00:00 Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026 https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://www.palestinehealthreport.com/article/910565607-scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix Palestine Health Report en PressRelease 2026-05-05T17:00:00+00:00 Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.palestinehealthreport.com/article/910555990-american-nurses-association-calls-for-nurse-led-guardrails-on-artificial-intelligence-in-healthcare Palestine Health Report en PressRelease 2026-05-05T16:46:15+00:00 American Nurses Association Calls for Nurse-Led Guardrails on Artificial Intelligence in Healthcare https://ml.globenewswire.com/media/ZmJhMWViYzAtNWRmOS00MDI4LThjMGEtNGFiODlhNzc2ZjZjLTUwMDE2MTk2Mi0yMDI2LTA1LTA1LWVu/tiny/American-Nurses-Enterprise.png https://www.palestinehealthreport.com/article/910545481-valneva-to-report-first-quarter-2026-consolidated-financial-results-on-may-13-2026 Palestine Health Report en PressRelease 2026-05-05T15:45:00+00:00 Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://www.palestinehealthreport.com/article/910545482-valneva-publiera-ses-r-sultats-financiers-consolid-s-du-premier-semestre-le-13-mai-2026 Palestine Health Report en PressRelease 2026-05-05T15:45:00+00:00 Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://www.palestinehealthreport.com/article/910545526-allsup-named-usa-today-s-top-workplace-third-year-in-a-row Palestine Health Report en PressRelease 2026-05-05T15:27:44+00:00 Allsup Named USA Today’s Top Workplace Third Year In A Row https://ml.globenewswire.com/media/OTVmNmRkNjctYjAzMC00Y2M3LTg2OTktODg4ZmQ5NjYxOTYxLTEwOTcwODEtMjAyNi0wNS0wNS1lbg==/tiny/Allsup.png